Arkolith/Insider Trading/VOR/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerVor Biopharma Inc. (VOR) · full profile →Form 4 · filed Apr 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14.5M
Net Open-Market Flow
-$14.5M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 6, 2026Sell(S)538K$16.51$8.9M4.6M
Apr 6, 2026Sell(S)45K$17.31$774K4.6M
Apr 6, 2026Sell(S)7K$18.50$125K4.6M
Apr 2, 2026Sell(S)258K$18.23$4.7M5.1M
Apr 2, 2026Sell(S)2K$19.06$29K5.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000320) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML